The most cited single result is from Yun and colleagues in 2018, who showed that NLY01, a long-acting PEGylated GLP-1R agonist, blocked the microglia-driven conversion of resting astrocytes into the neurotoxic A1 phenotype in mouse models, a process implicated in neuronal death in both Parkinsons and Alzheimers disease [4]
So that's a great question
However, GLP-1 therapies may provide additional benefits when used together with other treatments
Ready to see how effortless GLP-1 nutrition can be
& Poitout, V
Its important to understand: This warning is not related to hypothyroidism itself Having hypothyroidism does not prevent you from taking Wegovy A history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) does prevent you from taking Wegovy Telling side effects apart Some side effects of Wegovy, such as nausea, tiredness, and constipation, can be similar to symptoms of poorly controlled hypothyroidism